Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR
暂无分享,去创建一个
M. Marra | A. Abbruzzese | M. Caraglia | B. Vincenzi | P. Stiuso | R. Addeo | S. Prete | S. Naviglio | G. Giuberti | L. Montella | P. Sperlongano | M. Murolo